Inhibrx Biosciences revenue was $200.00k for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $0.0, down 100% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INBX annual revenue was $200.0k, with -88.9% growth year-over-year.
INBX past revenue growth
How has INBX's revenue growth performed historically?
Inhibrx Biosciences (NASDAQ: INBX) reported Q1 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Inhibrx Biosciences's revenue was $0.00.
What was Inhibrx Biosciences's revenue in 2024?
Inhibrx Biosciences's annual revenue for the twelve months ending Dec 31, 2024 was $200.00 thousand, a 88.89% decrease year over year.
How much does Inhibrx Biosciences make in a day?
Based on Inhibrx Biosciences annual revenue for the past two years, INBX makes an average of $2,739.73 per day.
What was Inhibrx Biosciences's annual revenue growth in the past year?
As of Q3 2025, Inhibrx Biosciences's revenue has grown -88.78% year over year. This is 1,705.76 percentage points lower than the US Biotechnology industry revenue growth rate of 1,616.97%. Inhibrx Biosciences's revenue in the past year totaled $200.00 thousand.
How much does Inhibrx Biosciences make in a year?
Inhibrx Biosciences's revenue by year for the past two years is:
Inhibrx Biosciences's revenue for the twelve months ending Dec 31, 2024 was $200.00 thousand, a 88.89% decrease year over year.
Inhibrx Biosciences's annual revenue for Dec 31, 2023 was $1.80 million, a 17.88% decrease from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.